Annual Report 2025
“We will successfully shape the transformation that lies ahead of us. Because we not only have the right products and solutions for the future, but above all the right team.”
Dr. Christian Hartel
President and CEO
Highlights 2025
WACKER is more than a global specialty chemicals and biotech company. WACKER is the future. A community built on clear values and one that continued to actively drive progress in 2025.
WACKER at a glance
Sales
€5.5 billion
2024: €5.7 billion
Sales by region
-
Europe
40%
-
Asia
35%
-
The Americas
19%
-
Other regions
6%
Sales by business division
-
Silicones
€2,733 million
-
Polymers
€1,379 million
-
Biosolutions
€360 million
-
Polysilicon
€883 million
EBITDA
€427 million
2024: €743 million
Employees
16,467
2024: 16,637
Capital expenditures
€466 million
2024: €709 million
Research and development expenses
€215 million
2024: €204 million
Active patents
3,400
2024: 3,100
Absolute greenhouse gas emissions (Scopes 1 and 2)
Base year 2020 = 100%
Target in 2030 = –50%
in million metric tons CO2e
Share of renewable sources in our total energy consumption
34%
2024: 34%